Jeff Duchemin Appointed as President and CEO of Fotona® to Accelerate Growth
FotonaⓇ, a global leader in high-performance laser systems and energy-based devices, has announced the appointment of Jeff Duchemin as President and Chief Executive Officer. This strategic move comes as the company looks to tap into Duchemin's extensive leadership experience in the MedTech sector, which spans decades and includes pivotal roles in both U.S. and international markets.
Before his tenure at Fotona, Duchemin held significant leadership positions at Becton Dickinson in the Interventional Surgery and Integrated Diagnostics divisions. His previous experience also includes serving as the President and CEO of Harvard Biosciences, showcasing his deep expertise in driving revenue growth through organic development and strategic acquisitions. Duchemin's proven track record will play a crucial role in fostering innovation at Fotona and expanding its global footprint.
Expressing enthusiasm about his new role, Duchemin stated, "Innovation is at the core of Fotona. I am passionate about accelerating growth by enhancing our existing solutions and launching groundbreaking technologies. Fotona has a solid foundation, exceptional talent, and world-class products. It is a privilege to lead the company at such a crucial point in its development."
Jay Katzen, the Executive Chairman of Fotona, praised Duchemin as a visionary leader with a strong record in the biosciences and medical devices sector. "We are excited to have him onboard, guiding Fotona through the next chapter of innovation and market leadership, backed by industry-leading expertise and solutions."
Fotona celebrated its 60th anniversary last year, marking a legacy filled with technological innovations in laser systems. The company has pioneered numerous advancements in the industry, including the groundbreaking integration of dual laser wavelengths (ErYAG and NdYAG) into a single system. Recently, Fotona launched the Dynamis® Max, its next-generation aesthetic platform that offers increased versatility, improved user-friendliness, and enhanced treatment efficiency, supporting over 100 advanced treatment applications.
The company’s strengths lie not only in its cutting-edge technology but also in its commitment to education and support for its laser users. Fotona boasts one of the industry's most trained workforces, featuring a significant number of PhDs specializing in laser and medical technology innovations. With a strong presence in markets like the United States, China, Japan, and the European Union, Fotona serves over 70 countries worldwide, ensuring comprehensive support and service for its laser systems.
As he steps into this new role, it’s clear that Jeff Duchemin's leadership will be instrumental in steering Fotona towards a future ripe with opportunity and innovation. The company’s robust portfolio and dedication to advancing laser technologies are set to push the boundaries of what's possible in aesthetic, dental, and gynecological applications, ultimately elevating the standards of care in these fields.
For more information about Fotona and their latest innovations, please visit Fotona.com.
Before his tenure at Fotona, Duchemin held significant leadership positions at Becton Dickinson in the Interventional Surgery and Integrated Diagnostics divisions. His previous experience also includes serving as the President and CEO of Harvard Biosciences, showcasing his deep expertise in driving revenue growth through organic development and strategic acquisitions. Duchemin's proven track record will play a crucial role in fostering innovation at Fotona and expanding its global footprint.
Expressing enthusiasm about his new role, Duchemin stated, "Innovation is at the core of Fotona. I am passionate about accelerating growth by enhancing our existing solutions and launching groundbreaking technologies. Fotona has a solid foundation, exceptional talent, and world-class products. It is a privilege to lead the company at such a crucial point in its development."
Jay Katzen, the Executive Chairman of Fotona, praised Duchemin as a visionary leader with a strong record in the biosciences and medical devices sector. "We are excited to have him onboard, guiding Fotona through the next chapter of innovation and market leadership, backed by industry-leading expertise and solutions."
Fotona celebrated its 60th anniversary last year, marking a legacy filled with technological innovations in laser systems. The company has pioneered numerous advancements in the industry, including the groundbreaking integration of dual laser wavelengths (ErYAG and NdYAG) into a single system. Recently, Fotona launched the Dynamis® Max, its next-generation aesthetic platform that offers increased versatility, improved user-friendliness, and enhanced treatment efficiency, supporting over 100 advanced treatment applications.
The company’s strengths lie not only in its cutting-edge technology but also in its commitment to education and support for its laser users. Fotona boasts one of the industry's most trained workforces, featuring a significant number of PhDs specializing in laser and medical technology innovations. With a strong presence in markets like the United States, China, Japan, and the European Union, Fotona serves over 70 countries worldwide, ensuring comprehensive support and service for its laser systems.
As he steps into this new role, it’s clear that Jeff Duchemin's leadership will be instrumental in steering Fotona towards a future ripe with opportunity and innovation. The company’s robust portfolio and dedication to advancing laser technologies are set to push the boundaries of what's possible in aesthetic, dental, and gynecological applications, ultimately elevating the standards of care in these fields.
For more information about Fotona and their latest innovations, please visit Fotona.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.